PanGenex (PGXC) and Incredible Discoveries® Partner in Nationwide Infomercial Campaign for Calci-CLEAR™

TAMPA, Fla.--(EON:Enhanced Online News)--PanGenex Corporation (Pink Sheets:PGXC) announces that it has signed an agreement to partner with Incredible Discoveries® in the launch of a national marketing campaign for Calci-CLEAR™. Calci-CLEAR is a nutraceutical supplement designed to address soft-tissue calcification. Calci-CLEAR was formulated following years of research across a variety of studies and is on the heel of news organizations and institutions such as the New England Journal of Medicine, CNN, BusinessWeek, the American College of Cardiology and others reporting on the findings from the University of California that states that ‘measuring calcium deposits in the arteries of the heart is a good predictor of future heart disease.’ Over 196 million people in the United States are diagnosed with diseases involving soft-tissue calcification at an overall cost to treat such diseases of $538 billion.

“Over the next several weeks as the campaign is developed, we will release additional information to our shareholders about this tremendous opportunity to partner with an industry leader such as Incredible Discoveries®.”

“We are very excited for the opportunity to be selected by Incredible Discoveries® to bring Calci-CLEAR to the national marketplace through the production of a 30-minute infomercial, strategic web advertising and continuity follow-up,” explains Jeff Roman, President and CEO of PanGenex Corporation. “Over the next several weeks as the campaign is developed, we will release additional information to our shareholders about this tremendous opportunity to partner with an industry leader such as Incredible Discoveries®.”

About Incredible Discoveries®:

Incredible Discoveries®, a wholly-owned subsidiary of O2Media Inc., is a fully integrated production, marketing and investment partnership company that introduces new products to consumers through infomercial development and multi-channel marketing opportunities, including international retail distribution, the highest rated live shopping networks, direct mail catalogs, and insert programs. In addition, Incredible Discoveries® offers a funding option for select product manufacturers that is totally unique to the industry. Incredible Discoveries® hosts a team of dynamic professionals with years of direct response ingenuity and expertise. Their fresh innovative approach has led to successful product launches including the Tornado and the Magic Juice Filter, as well as the international launch of the Didi Car. The organization is a valued member of the Electronic Retailing Association (ERA) and the Direct Response Marketing Alliance (DRMA). For more information about Incredible Discoveries, please visit their website at www.incrediblediscoveries.com.

About PanGenex Corporation:

PanGenex is a publicly traded corporation (Pink Sheets:PGXC) and pursues business opportunities in the $70 billion nutraceutical and dietary supplement industry. With a focus on the cardiovascular health segment, PanGenex develops and markets sector leading, patented or patent pending, condition specific nutraceuticals and topical over-the-counter (OTC) drugs and personal care products. Each product is scientifically formulated to address specific health conditions. Many of our products contain the purest grade of nutraceutical components available anywhere without a prescription. PanGenex markets products through healthcare practitioners, retail establishments and the internet on websites such as www.PanGenex.com, www.Calgenex.com and www.HeartHealthyWorld.com.

Disclaimer:

Cautionary Statement about Forward-Looking Statements

This press release contains "forward-looking statements," which are statements related to future, not past, events. In this context, the forward-looking statements often include statements regarding our goals, plans, projections and guidance regarding our financial position, results of operations, market position, pending and potential future acquisitions and business strategy, and often contain words such as "expects," "anticipates," "intends," "plans," "believes," "seeks" or "will." Any such forward-looking statements are not assurances of future performance and involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. These risks and uncertainties include, among other things, (a) general economic and business conditions, (b) the level of strategic partner incentives, (c) the future regulatory environment, (d) our cost of financing, (e) our ability to complete acquisitions and dispositions and the risks associated therewith, and (f) our ability to retain key personnel. These factors, as well as additional factors, could affect our forward-looking statements. We urge you to carefully consider this information. We undertake no duty to update our forward-looking statements, including our earnings outlook. The statements in this press release have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.